2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
MRI (Magnetic Resonance Imaging)
Magnetic Resonance Imaging (MRI) plays a pivotal role in cancer research by offering non-invasive insights into tumor detection, characterization, and treatment response assessment. Its high-resolution imaging capability provides detailed anatomical information, aiding in precise tumor localization and staging. Moreover, advanced MRI techniques like diffusion-weighted imaging and dynamic contrast-enhanced MRI enable researchers to assess tumor microstructure, vascularity, and metabolic activity, crucial for understanding tumor behavior and predicting treatment outcomes. In cancer research, MRI serves as a valuable tool for monitoring treatment efficacy and detecting early signs of tumor recurrence, facilitating personalized therapeutic strategies. Additionally, ongoing advancements in MRI technology, such as functional MRI and spectroscopy, hold promise for further enhancing our understanding of cancer biology and improving patient care.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China